Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Cleveland BioLabs stock

Own Cleveland BioLabs stock in just a few minutes.

Cleveland BioLabs, Inc is a biotechnology business based in the US. Cleveland BioLabs shares (CBLI) are listed on the NASDAQ and all prices are listed in US Dollars. Cleveland BioLabs employs 2 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Cleveland BioLabs

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CBLI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Cleveland BioLabs share price

Use our graph to track the performance of CBLI stocks over time.

Cleveland BioLabs shares at a glance

Information last updated 2021-04-30.
52-week range$1.43 - $9.53
50-day moving average $5.74
200-day moving average $4.45
Wall St. target price$2.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.27

Buy Cleveland BioLabs shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cleveland BioLabs stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cleveland BioLabs financials

Revenue TTM $262,942
Gross profit TTM $-428,128
Return on assets TTM -74.24%
Return on equity TTM -162.65%
Profit margin 0%
Book value $-0.26
Market capitalisation $85.1 million

TTM: trailing 12 months

Shorting Cleveland BioLabs shares

There are currently 108,660 Cleveland BioLabs shares held short by investors – that's known as Cleveland BioLabs's "short interest". This figure is 99% up from 54,593 last month.

There are a few different ways that this level of interest in shorting Cleveland BioLabs shares can be evaluated.

Cleveland BioLabs's "short interest ratio" (SIR)

Cleveland BioLabs's "short interest ratio" (SIR) is the quantity of Cleveland BioLabs shares currently shorted divided by the average quantity of Cleveland BioLabs shares traded daily (recently around 205018.86792453). Cleveland BioLabs's SIR currently stands at 0.53. In other words for every 100,000 Cleveland BioLabs shares traded daily on the market, roughly 530 shares are currently held short.

However Cleveland BioLabs's short interest can also be evaluated against the total number of Cleveland BioLabs shares, or, against the total number of tradable Cleveland BioLabs shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cleveland BioLabs's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Cleveland BioLabs shares in existence, roughly 10 shares are currently held short) or 0.0122% of the tradable shares (for every 100,000 tradable Cleveland BioLabs shares, roughly 12 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Cleveland BioLabs.

Find out more about how you can short Cleveland BioLabs stock.

Cleveland BioLabs share dividends

We're not expecting Cleveland BioLabs to pay a dividend over the next 12 months.

Have Cleveland BioLabs's shares ever split?

Cleveland BioLabs's shares were split on a 1:20 basis on 27 January 2015. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cleveland BioLabs shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Cleveland BioLabs shares which in turn could have impacted Cleveland BioLabs's share price.

Cleveland BioLabs share price volatility

Over the last 12 months, Cleveland BioLabs's shares have ranged in value from as little as $1.43 up to $9.53. A popular way to gauge a stock's volatility is its "beta".

CBLI.US volatility(beta: 0.7)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cleveland BioLabs's is 0.7038. This would suggest that Cleveland BioLabs's shares are less volatile than average (for this exchange).

Cleveland BioLabs overview

Cleveland BioLabs, Inc. , a biopharmaceutical company, develops novel approaches to activate the immune system and address various medical needs in the United States and Russia. Its proprietary platform of toll-like immune receptor activators (TLR) has applications in mitigation of radiation injury, radiation oncology, and immuno-oncology. The company's product candidate is entolimod, an immune-stimulatory agent, which is used as a medical radiation countermeasure and other indications in radiation oncology. It is also developing Mobilan, a recombinant non-replicating adenovirus that directs expression of TLR5 and its agonistic ligand; and CBL0137, a small molecule with a multi-targeted mechanism for the treatment of various types of cancer. Cleveland BioLabs, Inc. has strategic partnerships with the Cleveland Clinic, Roswell Park Cancer Institute, Rusnano, and Everon Biosciences.

Frequently asked questions

What percentage of Cleveland BioLabs is owned by insiders or institutions?
Currently 50.262% of Cleveland BioLabs shares are held by insiders and 4.035% by institutions.
How many people work for Cleveland BioLabs?
Latest data suggests 2 work at Cleveland BioLabs.
When does the fiscal year end for Cleveland BioLabs?
Cleveland BioLabs's fiscal year ends in December.
Where is Cleveland BioLabs based?
Cleveland BioLabs's address is: 73 High Street, Buffalo, NY, United States, 14203
What is Cleveland BioLabs's ISIN number?
Cleveland BioLabs's international securities identification number is: US1858602022
What is Cleveland BioLabs's CUSIP number?
Cleveland BioLabs's Committee on Uniform Securities Identification Procedures number is: 185860103

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site